Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Other-Cashflows-From-Financing-Activities" stands at 9.05 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.28 percent compared to the value the year prior.
The 1 year change in percent is -3.28.
The 3 year change in percent is 11.34.
The 5 year change in percent is 16.82.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Cashflows From Financing Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Cashflows From Financing Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Cashflows From Financing Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Cashflows From Financing Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Cashflows From Financing Activities | 280,205,508,085.11 |